Mineralys Therapeutics
MLYS
MLYS
92 hedge funds and large institutions have $541M invested in Mineralys Therapeutics in 2024 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 24 increasing their positions, 34 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
1.38% less ownership
Funds ownership: 85.74% → 84.37% (-1.4%)
29% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 34
Holders
92
Holding in Top 10
5
Calls
$129K
Puts
$81K
Top Buyers
| 1 | +$41.1M | |
| 2 | +$26.1M | |
| 3 | +$21.6M | |
| 4 |
SB
Samsara BioCapital
Palo Alto,
California
|
+$7.17M |
| 5 |
VA
VR Adviser
New York
|
+$7.17M |
Top Sellers
| 1 | -$11.3M | |
| 2 | -$7.09M | |
| 3 | -$5.5M | |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$4.84M |
| 5 |
Millennium Management
New York
|
-$4.43M |